You are here

Home / Resources / Key Material
Export 69 results:
Filters: First Letter Of Last Name is O  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
World Health Organization (2003).  Adherence to long-term therapies: evidence for action.
Kaya, A., Tasyaran M., Erol S., Ozkurt Z., & Ozkan B. (2002).  Anthrax in adults and children: a review of 132 cases in Turkey. European journal of clinical microbiology & infectious diseases. 21, 258–261.
Kaya, A., Tasyaran M., Erol S., Ozkurt Z., & Ozkan B. (2002).  Anthrax in adults and children: a review of 132 cases in Turkey. European journal of clinical microbiology & infectious diseases. 21, 258–261.
Kaya, A.., Tasyaran M.., Erol S.., Ozkurt Z.., & Ozkan B.. (2002).  Anthrax in Adults and Children: A Review of 132 Cases in Turkey. Eur J Clin Microbiol Infect Dis. 21, 258-261.
Kaya, A.., Tasyaran M.., Erol S.., Ozkurt Z.., & Ozkan B.. (2002).  Anthrax in Adults and Children: A Review of 132 Cases in Turkey. Eur J Clin Microbiol Infect Dis. 21, 258-261.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
B
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., et al. (2001).  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
C
Cowen, K. A., & Ollison W. M. (2006).  Continuous monitoring of particle emissions during showering. Journal of the Air & Waste Management Association. 56, 1662–1668.
Cowen, K. A., & Ollison W. M. (2006).  Continuous monitoring of particle emissions during showering. Journal of the Air & Waste Management Association. 56,
Chappell, C. L., Okhuysen P. C., Langer-Curry R., Widmer G., Akiyoshi D. E., Tanriverdi S., et al. (2006).  Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75, 5.
Tansey, J., & O'riordan T. (1999).  Cultural theory and risk: a review. Health, risk & society. 1, 71-90.
D
Ojielo, C. I., Cooke K., Mancuso P., Standiford T. J., Olkiewicz K. M., Clouthier S., et al. (2003).  Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation. The Journal of Immunology. 171(8), 4416 - 4424.
Ojielo, C. I., Cooke K., Mancuso P., Standiford T. J., Olkiewicz K. M., Clouthier S., et al. (2003).  Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation. The Journal of Immunology. 171(8), 4416 - 4424.
Ojielo, C. I., Cooke K., Mancuso P., Standiford T. J., Olkiewicz K. M., Clouthier S., et al. (2003).  Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. The Journal of Immunology. 171, 4416–4424.
Ojielo, C. I., Cooke K., Mancuso P., Standiford T. J., Olkiewicz K. M., Clouthier S., et al. (2003).  Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. The Journal of Immunology. 171, 4416–4424.
Atmar, RL., Opekun AR., Gilger MA., Estes MK., Crawford SE., & Neill FH. (2014).  Determination of the 50% Human Infectious Dose for Norwalk Virus. Journal of Infectious Diseases.
Watanabe, T.., Bartrand T.. A., Weir M.. H., Omura T.., & Haas C.. N. (2010).  Development of a Dose-Response Model for SARS Coronavirus. Risk Analysis: An International Journal. 30(7), 1129–1138.
Obiri‐Danso, K., & Jones K. (1999).  Distribution and seasonality of microbial indicators and thermophilic campylobacters in two freshwater bathing sites on the River Lune in northwest England. Journal of Applied Microbiology. 87(6), 
Njc, S., Doyle M.. P., Kasuga F.., Rotariu O.., & Ogden I.. D. (2005).  Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology. 103, 1.
Murphy, B. R., Clements M. L., Madore H. P., Steinberg J., O'Donnell S., Betts R., et al. (1984).  Dose Response of Cold-Adapted, Reassortant Influenza A/California/10/78 Virus (H1N1) in Adult Volunteers. Journal of Infectious Diseases. 149, 5.
Watanabe, T.., Bartrand T.. A., Omura T.., & Haas C.. N. (2012).  Dose-Response Assessment for Influenza A Virus Based on Data Sets of Infection with its Live Attenuated Reassortants. Risk Analysis. 32, 555–565.
E
O'Donnell, M., Platt C., & Aston R. (2000).  Effect of a boil water notice on behaviour in the management of a water contamination incident. Communicable Disease and Public Health. 3, 56–59.
Lei, X. Ping, Yi G., Wang K. Yu, OuYang P., Chen D. Fang, Huang X. Li, et al. (2019).  Elizabethkingia miricola infection in Chinese spiny frog (Quasipaa spinosa). Transboundary and Emerging Diseases. 66, 1049-1053.
G
World Health Organization (0).   Global task force on cholera control: prevention and control of cholera outbreaks: WHO policy and recommendations: Diagnosis.